S'abonner

Reduced fetal growth velocity and weight loss are associated with adverse perinatal outcome in fetuses at risk of growth restriction - 22/12/22

Doi : 10.1016/j.ajog.2022.06.023 
Tamara Stampalija, MD a, b, Hans Wolf, MD c, Bronacha Mylrea-Foley, MD d, e, Neil Marlow, MD f, Katie J. Stephens, MD e, Caroline J. Shaw, PhD d, e, Christoph C. Lees, MD d, e,
On behalf of

TRUFFLE-2 Feasibility Study authors

Bine Arabin, MD, Astrid Berger, MD, Eva Bergman, MD, Amarnath Bhide, MD, Caterina M. Bilardo, MD, Andrew C. Breeze, MD, Jana Brodszki, MD, Pavel Calda, MD, Elena Cesari, MD, Irene Cetin, MD, Jan B. Derks, MD, Catherine Ebbing, MD, Enrico Ferrazzi, MD, Tiziana Frusca, MD, Wessel Ganzevoort, MD, Sanne J. Gordijn, MD, Wilfried Gyselaers, MD, Kurt Hecher, MD, Philipp Klaritsch, MD, Ladislav Krofta, MD, Peter Lindgren, MD, Silvia M. Lobmaier, MD, Gisuseppe M. Maruotti, MD, Federico Mecacci, MD, Kirsti Myklestad, MD, Rafaele. Napolitano, MD, Federico Prefumo, MD, Luigi Raio, MD, Jute Richter, MD, Ragnar K. Sande, MD, Jim Thornton, MD, Herbert Valensise, MD, Gerry H.A. Visser, MD, Ling Wee, MD

a Unit of Fetal Medicine and Prenatal Diagnosis, Institute for Maternal and Child Health, Istituto di Ricovero e Cura a Carattere Scientifico Burlo Garofolo, Trieste, Italy 
b Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy 
c Department of Obstetrics and Gynecology, Amsterdam University Medical Center (Location AMC), University of Amsterdam, Amsterdam, The Netherlands 
d Institute of Developmental and Reproductive Biology, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom 
e Department of Fetal Medicine, Queen Charlotte's and Chelsea Hospital, Imperial College National Health Service Trust, London, United Kingdom 
f Institute for Womens Health, University College London, London, United Kingdom 

Corresponding author: Christoph C. Lees, MD.

Abstract

Background

Although fetal size is associated with adverse perinatal outcome, the relationship between fetal growth velocity and adverse perinatal outcome is unclear.

Objective

This study aimed to evaluate the relationship between fetal growth velocity and signs of cerebral blood flow redistribution, and their association with birthweight and adverse perinatal outcome.

Study Design

This study was a secondary analysis of the TRUFFLE-2 multicenter observational prospective feasibility study of fetuses at risk of fetal growth restriction between 32+0 and 36+6 weeks of gestation (n=856), evaluated by ultrasound biometry and umbilical and middle cerebral artery Doppler. Individual fetal growth velocity was calculated from the difference of birthweight and estimated fetal weight at 3, 2, and 1 week before delivery, and by linear regression of all available estimated fetal weight measurements. Fetal estimated weight and birthweight were expressed as absolute value and as multiple of the median for statistical calculation. The coefficients of the individual linear regression of estimated fetal weight measurements (growth velocity; g/wk) were plotted against the last umbilical-cerebral ratio with subclassification for perinatal outcome. The association of these measurements with adverse perinatal outcome was assessed. The adverse perinatal outcome was a composite of abnormal condition at birth or major neonatal morbidity.

Results

Adverse perinatal outcome was more frequent among fetuses whose antenatal growth was <100 g/wk, irrespective of signs of cerebral blood flow redistribution. Infants with birthweight <0.65 multiple of the median were enrolled earlier, had the lowest fetal growth velocity, higher umbilical-cerebral ratio, and were more likely to have adverse perinatal outcome. A decreasing fetal growth velocity was observed in 163 (19%) women in whom the estimated fetal weight multiple of the median regression coefficient was <−0.025, and who had higher umbilical-cerebral ratio values and more frequent adverse perinatal outcome; 67 (41%; 8% of total group) of these women had negative growth velocity. Estimated fetal weight and umbilical-cerebral ratio at admission and fetal growth velocity combined by logistic regression had a higher association with adverse perinatal outcome than any of those parameters separately (relative risk, 3.3; 95% confidence interval, 2.3–4.8).

Conclusion

In fetuses at risk of late preterm fetal growth restriction, reduced growth velocity is associated with an increased risk of adverse perinatal outcome, irrespective of signs of cerebral blood flow redistribution. Some fetuses showed negative growth velocity, suggesting catabolic metabolism.

Le texte complet de cet article est disponible en PDF.

Key words : adverse outcome, brain sparing, catabolism, cerebral blood flow redistribution, cerebro-placental ratio, Doppler, fetal growth restriction, growth velocity, hypoxemia, middle cerebral artery, small for gestational age, umbilical-cerebral ratio


Plan


 The authors report no conflict of interest.
 C.C.L. is supported by the UK National Institute for Health Research Biomedical Research Centre based at Imperial College Healthcare National Health Service Trust.
 Cite this article as: Stampalija T, Wolf H, Mylrea-Foley B, et al. Reduced fetal growth velocity and weight loss are associated with adverse perinatal outcome in fetuses at risk of growth restriction. Am J Obstet Gynecol 2023;228:71.e1-10.


© 2022  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 228 - N° 1

P. 71.e1-71.e10 - janvier 2023 Retour au numéro
Article précédent Article précédent
  • COVID-19 booster dose induces robust antibody response in pregnant, lactating, and nonpregnant women
  • Caroline Atyeo, Lydia L. Shook, Nadege Nziza, Elizabeth A. Deriso, Cordelia Muir, Arantxa Medina Baez, Rosiane S. Lima, Stepan Demidkin, Sara Brigida, Rose M. De Guzman, Madeleine D. Burns, Alejandro B. Balazs, Alessio Fasano, Lael M. Yonker, Kathryn J. Gray, Galit Alter, Andrea G. Edlow
| Article suivant Article suivant
  • Placental transcriptomic signatures of spontaneous preterm birth
  • Alison G. Paquette, James MacDonald, Theo Bammler, Drew B. Day, Christine T. Loftus, Erin Buth, W. Alex Mason, Nicole R. Bush, Kaja Z. Lewinn, Carmen Marsit, James A. Litch, Michael Gravett, Daniel A. Enquobahrie, Sheela Sathyanarayana

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.